# Francesco Pavese

**Type:** Researchers  
**Canonical URL:** https://scholariq.org/researchers/francesco-pavese/

## Facts

| Field | Value |
| --- | --- |
| Citations | 336 |
| Field | Breast Cancer Treatment Studies |
| h-index | 8 |
| i10-index | 5 |
| Last Known Institution | Università Cattolica del Sacro Cuore |
| OpenAlex ID | https://openalex.org/A5055028865 |
| ORCID iD | 0000-0002-4218-6726 |
| Works | 33 |

## Researcher papers

- [Dilated cardiomyopathy in dialysis patients—beneficial effects of carvedilol: a double-blind, placebo-controlled trial](https://scholariq.org/papers/dilated-cardiomyopathy-in-dialysis-patients-beneficial-effects-of-carvedilol-a/)
- [PI3K Inhibitors in Advanced Breast Cancer: The Past, The Present, New Challenges and Future Perspectives](https://scholariq.org/papers/pi3k-inhibitors-in-advanced-breast-cancer-the-past-the-present-new-challenges/)
- [BRCA Mutation Status in Triple-Negative Breast Cancer Patients Treated with Neoadjuvant Chemotherapy: A Pivotal Role for Treatment Decision-Making](https://scholariq.org/papers/brca-mutation-status-in-triple-negative-breast-cancer-patients-treated-with/)
- [Prospective Study Investigating the Efficacy and Safety of a Scalp Cooling Device for the Prevention of Alopecia in Women Undergoing (Neo)Adjuvant Chemotherapy for Breast Cancer](https://scholariq.org/papers/prospective-study-investigating-the-efficacy-and-safety-of-a-scalp-cooling/)
- [Anthracycline-Free Neoadjuvant Treatment in Patients with HER2-Positive Breast Cancer: Real-Life Use of Pertuzumab, Trastuzumab and Taxanes Association with an Exploratory Analysis of PIK3CA Mutational Status](https://scholariq.org/papers/anthracycline-free-neoadjuvant-treatment-in-patients-with-her2-positive-breast/)
- [Assessing the pathogenicity of BRCA1/2 variants of unknown significance: Relevance and challenges for breast cancer precision medicine](https://scholariq.org/papers/assessing-the-pathogenicity-of-brca1-2-variants-of-unknown-significance/)
- [Real life outcome analysis of breast cancer brain metastases treated with Trastuzumab Deruxtecan](https://scholariq.org/papers/real-life-outcome-analysis-of-breast-cancer-brain-metastases-treated-with/)
- [Duration of response to first androgen deprivation therapy, time to castration resistance prostate cancer, and outcome of metastatic castration resistance prostate cancer patients treated with abiraterone acetate](https://scholariq.org/papers/duration-of-response-to-first-androgen-deprivation-therapy-time-to-castration/)
- [The PERSONS score for symptoms assessment in simultaneous care setting: A pilot study](https://scholariq.org/papers/the-persons-score-for-symptoms-assessment-in-simultaneous-care-setting-a-pilot/)
- [The possible different roles of denosumab in prevention and cure breast cancer bone metastases: A ‘hypothesis‑generator’ study from clinical practice](https://scholariq.org/papers/the-possible-different-roles-of-denosumab-in-prevention-and-cure-breast-cancer/)

## Researcher topics

- [Breast Cancer Treatment Studies](https://scholariq.org/topics/breast-cancer-treatment-studies/)
- [HER2/EGFR in Cancer Research](https://scholariq.org/topics/her2-egfr-in-cancer-research/)
- [Cancer Treatment and Pharmacology](https://scholariq.org/topics/cancer-treatment-and-pharmacology/)
- [Cancer survivorship and care](https://scholariq.org/topics/cancer-survivorship-and-care/)
- [BRCA gene mutations in cancer](https://scholariq.org/topics/brca-gene-mutations-in-cancer/)

## Researcher university

- [Università Cattolica del Sacro Cuore](https://scholariq.org/institutions/universita-cattolica-del-sacro-cuore/)

---
Source: ScholarIQ — public research metadata, principally OpenAlex. See https://scholariq.org/sources/ for provenance and https://scholariq.org/methodology/ for what these figures mean.